High-throughput antibody engineering in mammalian cells by CRISPR/Cas9-mediated homology-directed mutagenesis

Antibody engineering is often performed to improve therapeutic properties by directed evolution, usually by high-throughput screening of phage or yeast display libraries. Engineering antibodies in mammalian cells offer advantages associated with expression in their final therapeutic format (full-len...

Descripción completa

Detalles Bibliográficos
Autores principales: Mason, Derek M, Weber, Cédric R, Parola, Cristina, Meng, Simon M, Greiff, Victor, Kelton, William J, Reddy, Sai T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Synthetic Biology and Bioengineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101513/
https://www.ncbi.nlm.nih.gov/pubmed/29931269
http://dx.doi.org/10.1093/nar/gky550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101513/
https://www.ncbi.nlm.nih.gov/pubmed/29931269
http://dx.doi.org/10.1093/nar/gky550

Ejemplares similares